Loyola Medicine named to Becker's 2024 List of Great Orthopaedic and Oncology Programs

FOR IMMEDIATE RELEASE
Media Contact: Allison Peters
Phone: 708-216-6140
allison.peters@luhs.org

MAYWOOD, IL – Loyola Medicine has been named to Becker's Healthcare Review's 2024 list of 100+ Hospitals and Health Systems with Great Oncology Programs, as well as 100 Hospitals and Health Systems with Great Orthopedic Programs.

"It is an honor for Loyola Medicine’s Cardinal Bernardin Cancer Center and Nancy W. Knowles Orthopaedic Institute to be recognized by Becker’s Healthcare Review," said Shawn P. Vincent, president and CEO of Loyola Medicine. "This is a testament to the physicians, researchers, nurses and all staff who provide exceptional, compassionate care each and every day."

According to Becker's, the Great Oncology Programs list features "cancer centers with globally renowned experts, innovative clinical trials and intensive safety protocols," while the list of Great Orthopedic Programs recognizes devotion to delivering comprehensive, compassionate care for patients experiencing musculoskeletal conditions and injuries.

Becker's editorial team took several rankings and awards into consideration, including U.S. News & World Report, Newsweek and other top rankings organizations. Hospitals cannot pay for inclusion on the list.

"We are honored to be recognized as a top oncology program, reflecting our unwavering commitment to advancing cancer care, research, education and delivering hope to patients and families," said William Small Jr., MD, FACRO, FACR, FASTRO, chair of the department of radiation oncology and director of the Cardinal Bernardin Cancer Center at Loyola. "Great oncology programs are built by extraordinary people, and our staff exemplifies this every day with their dedication, talent and passion to our patients."

“Loyola’s inclusion on Becker’s Healthcare Review’s list of the nation’s best programs is a recognition of the exceptional teamwork of our highly skilled orthopaedic nurses, physical therapists, advanced practitioners and support staff that allow our physicians to help patients reach their goals and objectives," said Alexander J. Ghanayem, MD, FAOA, chair of Loyola Medicine's department of orthopaedic surgery and rehabilitation. "Our mission is clear: to keep our patients front and center with all colleagues aligned to help them succeed."

Loyola Medicine’s Cardinal Bernardin Cancer Center addresses a wide range of cancers. Its research contributions include a groundbreaking 2018 breast cancer study on the 21-gene test, which transformed breast cancer treatment and improved outcomes for tens of thousands of patients. Loyola’s innovations also include being the first in Illinois to implement technologies such as the Paxman Scalp Cooling System, MRIdian Linac for precision radiation therapy, and on-site CAR T-cell therapy manufacturing, which enhances treatment efficiency and accessibility. Loyola also emphasizes whole-person care, offering therapeutic services at the Coleman Foundation Image Renewal Center and achieving accreditation for cellular therapies like bone marrow transplants. Loyola’s adult bone marrow/stem cell program earned Blue Distinction Center+ status in 2023.

Loyola Medicine’s Nancy W. Knowles Orthopaedic Institute offers a comprehensive range of services, including expertise in joint reconstruction, orthopedic oncology, trauma, pediatrics and sports medicine. The department also provides specialized care for conditions related to the foot and ankle, hand/wrist, shoulder/elbow and spine. In 2016, Loyola became the first center in Illinois, and one of only nine in the U.S., to be accredited by the American Physical Therapy Association for post-professional residency programs in women’s health. In 2024, Loyola launched its women's sports medicine program, the first of its kind in the Chicagoland area, focusing on the health care needs of female athletes.